Abstracts

Keynote Session

1 MOLECULES CRAFTED TO SPY ON CELLS AND TUMORS

Roger Y. Tsien1 1University of California, San Diego, Pharmacology, School of Medicine, La Jolla, California

Genetically encoded tags and indicators are molecular spies that reveal specific gene products and biochemical processes in living cells and organisms. Fluorescent proteins from jellyfish and corals have been bred to eliminate multimerization and cover the entire visible spectrum. Somatic hypermutation in B lymphoma cells harnesses the immune system to produce a powerful new way to evolve protein properties. Indicators constructed from fluorescent proteins can report local dynamic signals such as redox potential, neurotransmitter concentrations, protein-protein interactions, and kinase vs. phosphatase activities. Although fluorescent proteins are powerful tools, they cannot be reduced below ~220 amino acids, and their only useful readout is fluorescence. Much shorter peptide sequences combine genetic encoding with the greater range of spectroscopic properties available by organic synthesis. Tetracysteine motifs of 6-12 amino acids can be labeled in live cells with membrane-permeant biarsenical dyes. Unique applications include green vs. red pulse-chase labeling of old vs. new copies of the same protein, electron-microscopic localization, chromophore-assisted light inactivation of a chosen protein without the problems of antibody penetration, and measurement of local Ca2+ within nanometers of proteins such as Ca2+ channels. For clinical applications one would prefer not to have to introduce genes or be limited to optical detection. Arginine-rich sequences are known to mediate uptake of a wide variety of contrast agents into cells and tissues in vivo. We find that such uptake can be prevented by appending certain polyanionic sequences and selectively re-activated by cleavage of the linker. This new mechanism offers the exciting possibility that radioactive, magnetic, and infrared contrast agents and therapeutic drugs may be concentrated in diseased tissues expressing particular extracellular proteases.

Frontiers Lecture Series

2 SINGLE CELL KINASE SIGNALING FOR MECHANISTIC AND CLINICAL ANALYSES

Garry P. Nolan1 1Stanford University, Microbiology and Immunology, School of Medicine, Stanford, California

Intracellular assays of signaling systems has been limited by an inability to correlate functional subsets of cells in complex populations based on active kinase states or other nodal signaling junctions. Such correlations could be important to distinguish changes in signaling status that arise in rare cell subsets during functional activation or in disease manifestation. Simultaneous detection of activated kinases and phosphoproteins in simultaneous pathways in subpopulations of complex cell populations by multi-parameter flow cytometric analysis allows identification of signaling cascades for disease states by ordering of kinase activation and phosphoprotein status in signaling hierarchies. Importantly, we demonstrate that ordering of these activations requires multiple interrogations of cells, and that the networks discovered are reflective of deeper correlations. Using Bayesian Network analysis (a form of machine learning) one can infer pathway connectivity in an automated fashion, allowing for high throughput derivations of signaling system networks graphs in PRIMARY CELLS. Notably, when kinase inhibitors, previously selected in in vitro assays are tested on complex cell populations, single cell analysis of signaling states reveals shocking differences in the inhibition of kinase activity in different cell subsets that will be discussed. The approach has powerful applications in mechanistic understanding, drug screening, and patient stratification for prediction of disease outcome in cancer, autoimmunity, infection, based on signaling network status. (1) Irish J.M., Hovland R., Krutzik P.O., Perez O.D., Bruserud O., Gjertsen B.T., Nolan G.P. (2004) Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer Cells. Cell. 118:217-228. (2) Sachs K., Perez O., Pe’er D., Lauffenburger

D.A and Nolan G.P. 2005. Causal protein-signaling networks derived from multiparameter single-cell data. Science. 308:523-9.

3 LOCATION PROTEOMICS: IMAGE INFORMATICS FOR SYSTEMS BIOLOGY

Robert F. Murphy1 1Carnegie Mellon University, Biological Sciences & Biomedical Engineering, Mellon College of Science & Carnegie Institute of Technology, Pittsburgh, Pennsylvania

Systems Biology requires comprehensive, systematic data on all aspects and levels of biological organization and function. In addition to information on the sequence, structure, activities, and binding interactions of all biological macromolecules, the creation of accurate, predictive models of cell behavior will require detailed information on the distributions of those molecules within cells and the ways in which those distributions change over the cell cycle and in response to mutations or external stimuli. Current information on subcellular location in protein databases is limited to unstructured text descriptions or sets of terms assigned by human curators. These entries do not permit basic operations that are common to other biological databases, such as measurement of the degree of similarity between the distributions of two proteins, and they are not able to fully capture the complexity of protein patterns that can be observed. The field of location proteomics seeks to provide automated, objective, high-resolution descriptions of protein location patterns within cells. The initial foundation for the field was the demonstration that automated classifiers could be trained to recognize all major subcellular patterns in fluorescence microscope images, and especially the critical finding was that such systems could discriminate location patterns better than visual examination. The very high accuracy (over 98% on single 3D images) of these systems gave confidence that the numerical features used to describe location patterns could form a basis for extending the methods to unsupervised learning of patterns. To this end, we have described grouping of proteins into statistically-indistinguishable location patterns using consensus clustering methods. The resulting clusters, or location families, are analogous to clusters found for other domains, such as protein sequence families. Our current work is focusing on extending this work in a number of new directions. These include analyzing the temporal dependence of subcellular patterns, generalizing pattern analysis across many cell types, analyzing mixed multicell images in cultures and tissues, and creating generative models of subcellular patterns that can be incorporated into comprehensive models of cell behavior. The combination of these methods with large scale, high throughput imaging approaches will allow realistic cell modeling that reflects detailed knowledge of the subcellular location of all proteins. We anticipate that work in this field will also lead to improved diagnostics based on subcellular pattern discrimination.

4 THE NIH CHEMICAL GENOMICS CENTER: ANNOTATING THE BIOLOGICAL ACTIVITY OF CHEMICAL LIBRARIES USING QUANTITATIVE HIGH THROUGHPUT SCREENING

Jim Inglese1 1National Institutes of Health (NIH), NIH Chemical Genomics Center, Bethesda, Maryland

The NIH Chemical Genomics Center (NCGC; www.ncgc.nih.gov/) is the founding member of the Molecular Libraries Screening Center Network (MLSCN), a network of ten centers established as part of the NIH Roadmap for Medical Research (nihroadmap.nih.gov/). The mission of the NCGC is to make accessible the technologies and protocols of high throughput biomolecular screening and chemistry optimization, developed primarily in the pharmaceutical and biotech industries, to academic investigators. The ‘product´ emerging from the NCGC pipeline will not be drugs, but rather chemical probes to aid in the understanding of biology and validation of therapeutic targets. In refining the screening process, the NCGC has developed a strategy called “quantitative HTS” (qHTS) to generate concentration-response curves for a range of biochemical and cellular assays on large compound collections using existing technologies. Our process is highly refractory to false positives, easily identifies compounds of low potency and efficacy, and demonstrates the potential to build high-quality chemical genomic databases. Examples from this new paradigm will be presented.

5 HIGH THROUGHPUT FLOW CYTOMETRY AND THE NIH ROADMAP MOLECULAR LIBRARIES INITIATIVE

Larry A. Sklar1, JeffreyArterburn2, Bruce Edwards3, Tudor I Oprea4, Eric R Prossnitz5, Herbert G Tanner6 1University of New Mexico, Cancer Researcn and Treatment Center and Pathology, Health Sciences Center, Albuquerque, New Mexico; 2New Mexico State University, Chemistry and Biochemistry, Las Cruces, New Mexico; 3University of New Mexico, Cancer Research and Treatment Center and Pathology, Albuquerque, New Mexico; 4University of New Mexico, Biochemistry and Molecular Biology, Albuquerque, New Mexico; 5University of New Mexico, Cell Biology and Physiology, Albuquerque, New Mexico; 6University of New Mexico, Mechanical Engineering, Albuquerque, New Mexico

The high throughput (HT) flow cytometry platform HyperCyt is adept at both cell and particle-based assays and is compatible with both high content and multiplex analysis. Our cell-based assays have initially been directed against G protein-coupled receptor (GPCR) targets where we have identified novel small molecule ligands for peptide and steroid receptors. We have developed general particle-based multiplexed approaches compatible with assemblies of soluble membrane receptors, receptor tails, proteases, kinases, nucleases, etc. We have probed the mechanism of partial agonism and the steps in signal transduction using flow cytometry-based kinetic analysis with soluble GPCR. We have also developed approaches probing cell-cell adhesion, nanoscale integrin conformational changes, and responses to nanoscale intercellular forces. The NIH Roadmap Molecular Libraries Initiative (MLI) has given us the opportunity, through the New Mexico Molecular Libraries Screening Center (NMMLSCN, http://nmmlsc/) to implement HT flow cytometry for the international research community. The MLSCN has expertise in: 1) target and assay development; 2) the integration of flow cytometric and virtual screening to enhance the discovery process; and 3) medicinal chemistry for the optimization of active molecules and the development of imaging agents. Through MLI and collaborations with investigators outside the MLSCN, we are currently developing cell-based assays for cytotoxicity where both cell viability and cell number can be recorded, bacterial virulence, multi-drug resistance, androgen response, protein expression, and generic cell responses, to name a few. We are also working on particle-based multiplexed protein-protein assays for interactions between Bcl-2 family members and generic protein-oligonucleotide interactions.

6 THE PHARMACODYNAMICS OF MOLECULAR CANCER THERAPEUTICS

David Hedley1 1Princess Margaret Hospital, Toronto, Ontario, Canada

Our approach to cancer is being revolutionized through rapid progress understanding the molecular mechanisms, coupled to rational drug design programs producing highly selective agents to target these mechanisms. Despite the current excitement, there are formidable obstacles to making effective molecular cancer therapeutics a clinical reality. Unlike classical chemotherapy and radiotherapy, the drugs are highly selective in their actions, and effective only when their molecular target is playing a significant role driving the malignant process. Due to the complex, multigenetic basis of cancer development, it is unlikely that a single molecular targeted agent could achieve long term cancer control in the clinic. More likely, optimal treatment will consist of combinations of agents, rationally selected based on understanding the downstream interactions of drug targets, and individualized by analysis of the patient´s tumour tissue. Fluorescence-based techniques using flow or image cytometry have major advantages studying complex biology, because they address the problems of cellular heterogeneity, and are able to study molecular interactions through the use of multiple fluorescence labels. The development of phosphospecific antibodies has allowed the introduction of techniques to study signal transduction at the single cell level, including the analysis of complex signaling interactions. This is of particular importance to molecular oncology, since a large number of agents currently in clinical trial inhibit signaling pathways. As well as measuring baseline activity to identify if the drug target is being expressed in the cancer cells, cytometric methods can also be used to monitor pharmacodynamic effects during treatment. Pharmacodynamics is a branch of pharmacology that asks how drugs impact on the host tissues, whereas pharmacokinetics studies how drugs are metabolized and eliminated by the patient. During the early phases of drug development, it is important to show that the drug is interacting with its target in vivo, and to determine the relationships between drug dose and the extent of target inhibition. Along with others, our group has been able to develop pharmacodynamic markers based on flow cytometry and fluorescence image analysis, validate these using experimental systems, and then translate the methods to the actual clinical situation. Pharmacodynamic information is critical to understanding what is going on in a patient´s cancer cells during treatment, in order to explain why treatment works in some patients but not in others. Although still in its infancy, cytometrybased pharmacodynamics has the potential to play a major role bridging between basic science, pathology, pharmacology, and molecular oncology.

7 SEARCHING FOR AN HIV VACCINE: THE ROLE OF FLOW CYTOMETRY

Mario Roederer1 1ImmunoTechnology Section, Laboratory of Immunology, Vaccine Research Center, NIAID, NIH, Bethesda, Maryland

Vaccine development to protect against HIV development is actively proceeding on two fronts: generation of a sterilizing (neutralizing) humoral response, and generation of an effective cellular response. To date, it has been impossible to generate an antibody response of sufficient potency that sterilizing vaccination is possible. Nonetheless, a vaccine can be considered successful on a global scale if the induced cellular response is sufficient to dampen viral loads (reducing transmission) as well as reducing morbidity and mortality after infection. We use a variety of adjuvants, delivery mechanisms, and immunogens to induce a variety of T cell responses. By challenging vaccinated nonhuman primates with live virus, we hope to identify the kinds of responses that are best correlated with protection as measured by a reduction in peak viral load, set point viral load, and amelioration of the dramatic destruction of memory CD4 T cells during acute infection. As we move forward through phase I and II clinical trials in humans, and prepare for phase III, we are keen to determine whether or not these types of responses are induced in humans as well. The primary tool for determining the quantity and quality of the T cell response is flow cytometry. Using sophisticated instrumentation, software, reagents, and techniques, we are able to measure five or more different functional responses simultaneously from each cell (e.g., cytokine profile, cytotoxic potential, proliferative capacity). These complex combinations of functions reveal that there are a number of distinct “flavors” of T cell responses present in either naturally infected or vaccinated subjects; the task now is to identify which of these flavors is most suited to protection from challenge. In addition, by studying rapid HIV progressors vs. long term nonprogressors, we are beginning to identify differences in T cell responses that are correlated with disease pathogenesis, perhaps pointing us towards desirable types of vaccine responses. Significant challenges remain, however. The automation of the sample analyses, the automation of the data analyses, compliance with GLP, and validation of these procedures is an enormous challenge. Integration and presentation of the highly complex datasets is still intensely laborious and challenging. In these terms, flow cytometry technology development is shifting from the instrumentation to the software and data interpretation aspects, which have yet to catch up to the rapid growth of the hardware capabilities.

8 FRONTIER LECTURE 4: HUMAN STEM CELL BIOLOGY AND POTENTIAL APPLICATIONS

Mickie Bhatia1 1McMaster University, Hamilton, Ontario, Canada

Dr. Bhatia’s program has characterized signaling pathways that regulate human stem cells and initiated new approaches of changing human stem cell behaviour. Using human to mouse xenotransplant systems to define human stem cells in the whole body, he has shown that growth factors normally abundant during fetal development can be introduced to adult stem cells and change their growth properties and ability to form other cell types. In parallel, Dr. Bhatia has demonstrated that cord blood stem cells have the potential of regenerating a damaged pancreas and correcting diabetic-like symptoms. Where human embryonic stem cells (hESCs) have been explored, his work provides evidence of the ability to generate blood stem cells from hESC lines and novel ways of growing hESC lines in culture. These findings provide novel procedures that may be useful in cell transplantation based regenerative therapies and continue to compare the effectiveness of adult and embryonic stem cells alike.

THE LCOS-BASED PROGRAMMABLE ARRAY MICROSCOPE (PAM)

Thomas M. Jovin1, Martin Thomas2, Guy M. Hagen1, Donna

J. Arndt-Jovin3, Keith A. Lidke4, Andrew Hill2, A. Martyn Reynolds2, Jeremy Graham2, Rainer Heintzmann5, Quentin Hanley6 1Max Planck Institute for Biophysical Chemistry, Molecular Biology, Goettingen, Niedersachsen, Germany; 2Cairn Research Ltd., Faversham, United Kingdom; 3Max Planck Institute for Biophysical Chemistry, Goettingen, Niedersachsen, Germany; 4Sandia National Laboratories, Biomolecular Materials and Interfaces Department, Albuquerque, New Mexico; 5King’s College London, New Hunt’s House, Randall Division of Cell and Molecular Biophysics, London, United Kingdom; 6Nottingham Trent University, School of Biomedical and Natural Sciences, Nottingham, United Kingdom

In 1998, we reported the realization of an optically sectioning fluorescence microscope (PAM) for rapid, light efficient 3D imaging of living specimens.1,2 The design was based on conjugate structured illumination & detection implemented with a spatial light modulator (SLM) located at an image plane of a conventional fluorescence microscope. The major advantages of the PAM are: (1) compact design with no moving parts; (2) very significant speedup/improvement in sectioning due to a pixel duty cycle of up to 50%, and simultaneous detection & processing of both conjugate (in-focus) & non-conjugate (out-of-focus) images; (3) ultrasensitive detection via electron multiplying CCD cameras; (4) programmable & adaptive optical sectioning based on libraries of dot, line & pseudo-random (Sylvester) sequence patterns; (5) flexible light sources, including LEDs; (6) generation & detection of arbitrarily polarization patterns; (7) compatibility with hyperspectral & lifetime-resolved imaging; (8) incorporation of light sources for photo-destruction and/or transformation, modes compatible with FRAP, FLIP & FCS/ICS; (9) minimal photobleaching. We report here the design, operation & application(s) of a new generation commercial PAM created by the combined efforts of the MPIbpc (Mol Biol Dept) and Cairn Research Ltd. (UK). The stand-alone module, including light source(s) and detector(s), features an innovative catadioptric design and a ferroelectric liquid-crystal-on-silicon (LCoS) SLM instead of the original DMD. It can be attached to a side port of a(ny) unmodified fluorescence microscope. The Cairn prototype system currently operated at the MPI incorporates a 6-position high-intensity LED illuminator and an Andor iXon emCCD camera, and is mounted on an Olympus IX71 inverted microscope with 60-150x objectives and a PZ translator, a Cairn Optoscan monochromator, and a Prior Scientific ProScan stage. Further enhancements are being incorporated: (i) point- and line-wise spectral resolution, detecting with an Applied Scientific Imaging SpectraCube imager or a Specim ImSpector imaging spectrograph; and (ii) lifetime imaging (FLIM) using phase-modulation2 and TCSPC modules. Multiphoton operation and other nonlinear techniques should be feasible. Real-time sectioning with 50-100 ms exposures and lag-free manual focusing have been achieved with a single LED source. Operation is insensitive to mechanical shock applied to the microscope table; thus, the system is suitable for ruggedized (field) use. It is currently being applied to developmental biology and signal transduction studies, e.g. based on quantum dot ligands3. 1Verveer PJ et al. 1998. J. Microsc.189:192; 2Hanley QS et al. 2005. Cytometry 67A:112 (latest PAM paper); 3Lidke DS et al. 2005. J. Cell Biol. 170:619.

10 CHEMICAL CYTOMETRY-ANALYTICAL CHEMISTRY OF SINGLE CELLS

Norman Dovichi1 1University of Washington, Chemistry Department, Seattle, Washington

It is now possible to generate one- and two-dimensional protein electrophoresis data from single mammalian cells. These separations are capable of resolving a hundred components from the cell, and the data can be correlated with cell cycle and other properties of the cells. Examples have been generated from breast, prostate, colon, and esophageal cancer cell lines, from macrophages, astrocytes and neurons, and from osteoprecursors and myoblasts. Instrumentation is under development that can characterize tens of thousands of cells per day in one-dimensional electrophoresis and thousands of cells per day in two-dimensional electrophoresis. Other instrumentation is able to detect specific proteins at the single copy level in single cells and determine post-translational modifications of that protein. Finally, metabollic pathways for both carbohydrates and glycolipids have been monitored in single cells.

Plenary Sessions

11 MULTIMODE LIVE CELL IMAGING REVEALS A NOVEL METHOD OF CELLULAR COMMUNICATION IN THE IMMUNE SYSTEM

Simon C. Watkins1 1University of Pittsburgh, Center for Biologic Imaging, School of Medicine, Pittsburgh, Pennsylvania

Engagement of cell surface receptors leads to intracellular signaling that has generally been shown to alter phenotype and function of individual cells. Using a variety of cutting edge optical imaging methods We show here that myeloid-lineage dendritic cells and monocytes can be triggered to flux calcium by mechanical contact with a microprobe, and that the signal can be propagated within seconds to other cells at distances up to a hundred microns away by membranous connections called tunneling nanotubules (TNTs). These form a complex and transient network in live cells, with individual TNTs exhibiting great variation in length and diameter. In addition to calcium fluxes, microinjected dye tracers can be transferred through these connections. Following TNT-mediated stimulation, spreading of lamellipodia occurs in dendritic cells characteristic of that seen during the phagocytic response to bacteria. These results demonstrate that functional signals generated in a single cell can be transmitted to other cells through a physically connected network.

12 FLUORESCENT SPECKLE MICROSCOPY

Gaudenz Danuser1 1The Scripps Research Institute, Department of Cell Biology, La Jolla, California

Fluorescent speckle microscopy (FSM) is a method to analyze the movement and assembly/disassembly dynamics of macromolecular structures. It capitalizes on fluorescent analog cytochemistry, in which purified protein is covalently linked to a fluorophore and microinjected or expressed as a GFP fusion in cells. Fluorescent protein coassembles with unlabeled, endogeneous protein, visualizing the localization and architectural organization of the structure inside a living cell. Despite its broad application, this classic approach has been limited in reporting subcellular dynamics because of the inherently high background fluorescence from unincorporated and out-of-focus incorporated fluorescent subunits and the uniform labeling of the target structure. However, if the labeled subunits make up less than 1% of total pool of subunits, fluorophore patterns of high non-uniformity accumulate. They provide a unique random code identifying specific subareas of the target structure in space and time. Addition of new fluorophores to the code indicates the local association of subunits; subtraction of fluorophores the local dissociation. These molecular events can be monitored by diffraction-limited imaging using wide-field, total internal reflection, or spinning disc confocal fluorescence microscopy equipped with sensitive CCD cameras. The resulting images display punctate patterns of local maxima, called speckles, over a dimmer background.

Speckles correspond to regions of the size of the point-spread-function with a higher fluorophore density and serve as fiduciary marks of the dynamics of the underlying structure. Although conceptually simple, the interpretation of FSM time-lapse sequences requires sophisticated computational tools for the tracking and statistical analysis of the intrinsically stochastic and highly convoluted signals. In this lecture I will cover the basic design of algorithms that simultaneously track thousands of speckles; and statistical models that allow the conversion of positional fluctuations and speckle intensity variations into spatiotemporally resolved maps of transport, turnover, and viscoelasticity of the probed structure. I will then report how quantitative FSM yielded major discoveries of the dynamic organization of the actin cytoskeleton in migrating cells and of the transient interaction of the cytoskeleton with other cellular assemblies such as focal adhesions. With a second set of examples I will indicate how we exploit the submicron resolution of this technique to infer molecular mechanisms of force generation during cell migration. Finally, I will illustrate the power of FSM as a general quantitative method for imaging the dynamics of any multiprotein structure in cells and in vitro.

13 FACILE GENERATION OF BIOSENSORS TO STUDY ENDOGENOUS PROTEIN ACTIVATION IN LIVING CELLS

Klaus Hahn1 1University of North Carolina at Chapel Hill, Department of Pharmacology, Chapel Hill, North Carolina

We are developing new methods for studying the spatio-temporal dynamics of signaling with minimal perturbation. By conjugating novel dyes to affinity reagents, activities of endogenous proteins can be studied with high sensitivity. This approach opens the door to high throughput generation of biosensors via phage display and other screening for biosensor affinity elements. The approach also readily permits analysis of multiple signaling activities in the same cell.

14 MULTIPLEXED HYBRID CYTOMETRY BASED APPLICATION PLATFORM TECHNOLOGY: A TOOL TO FIGHT THE HIV PANDEMIC IN THE 21ST CENTURY

Francis Mandy1 1Health Canada, Ottawa, Ontario, Canada

In sub-Saharan Africa about 12 million people perish every year from: HIV, malaria and tuberculosis. For the majority of the individuals who make up these gruesome annual statistics, the cause of death is uninvestigated. The introduction of affordable antiretroviral therapy (ART) in parts of Africa provides an opportunity to establish infrastructure to support laboratory medicine. This movement is a significant step in the direction of an effective health care system. Conventional laboratory medicine from resource rich regions is incompatible with African economical, cultural and political realities. In sub-Saharan countries 38% of the population exists on <$1 a day, with a gross national income per capita <$500. In the past, in most resource limited regions, founding agencies’ concentrated on disease prevention and provision of care. Until now, little effort has been exerted to build sustainable laboratory capacity. With the introduction of ART in Africa, health care policy makers and clinical scientist recognize the urgent need for affordable and sustainable laboratory infrastructure to support the diagnosis and treatment of HIV. For 25 years, flow cytometry has been the CD4 T-cell enumerating devic, to monitoring immune status of HIV infected individuals. Recently, numerous companies introduced affordable and robust cytometers both the flow and none-flow variety. Currently, the lower cost, dedicated instruments are the most popular choice for CD4 T-cell counting in Africa. Accumulative sales of these instruments are reaching significant numbers. When establishing affordable and sustainable comprehensive laboratory infrastructure is the overall long term objective; they in fact may turn out to be not the most cost effective option. In this presentation features of the hybrid flow based application platform (HyFAP) will be covered. The focus is on how to harness HyFAP and make economical sense in sub-Sahara Africa. They run both cell and microsphere based assays. Evidence will be presented to illustrate how a multi-functional and multiplexing capacity is a realistic option in resource poor countries. In the future, HyFAP will be connected to GSM wireless external quality monitoring services (WEMS). The integration with WEMS will assure minimum global standards for immunology laboratories. With HyFAP, it is possible to build laboratory capacity to provide rapid, accurate affordable and reliable diagnostic tests to battle infectious diseases in most resource poor regions of the globe.

15 REGULATION AND THERAPEUTIC TARGETING OF HUMAN LEUKEMIA STEM CELLS

Kristin Hope1, Liqing Jin2, Eric Lechman2, John Edgar Dick3 1University of Toronto, Toronto, Ontario, Canada; 2University Health Network, Cell and Molecular Biology, Toronto, Ontario, Canada; 3University of Toronto, Medical Genetics & Microbiology, Faculty of Medicine, Toronto, Ontario, Canada

In acute myeloid leukemia (AML) the leukemic clone is organized as a hierarchy originating from rare leukemic stem cells (LSC). Our interest has therefore been in identifying and therapeutically exploiting the molecular mechanisms that are uniquely required by these LSC. Although gene expression analysis is a common way of identifying the molecular players in stem cell function, few have explored the potential for microRNAs (miRNAs) in such a regulatory role. MiRNAs are 22 nucleotide (nt) non-coding RNAs processed from hairpin precursors that regulate translational repression of target genes. MiRNAs have been implicated in directing diverse biological processes including neoplasia. The identification of a set of embryonic stem cell specific miRNAs suggests that these may be involved in maintenance of the pluripotent state while a study linking miRNAs to fate determination showed ectopic expression of a specific miRNAs in hematopoietic progenitors could promote B or T cell differentiation. To address the role of miRNAs in the regulation of LSC we performed miRNA array analysis on 4 purified fractions based on CD34 and CD38 expression from 6 primary AMLs. We identified a unique miRNA signature that discriminates the CD34+CD38- fraction from more mature populations. One candidate, mir155, was also found to be differentially highly expressed in the stem cell fraction of normal cord blood by affymetrix array. RNAi-mediated knockdown of mir155 in a novel CD34+ leukemic cell line resulted in a loss of CD34 expression, an increase of differentiation antigen expression and significantly reduced proliferative potential. Our results are suggestive of a role for microRNAs in the regulation of LSC and leukemogenesis. In order to cure AML, LSC must be effectively targeted, however as existing therapeutic strategies target cycling cells and LSC are largely quiescent, new approaches must be found. We have shown previously that an activating monoclonal antibody (H90) directed against the adhesion molecule CD44 can release the AML differentiation block when administered in vitro. To address whether CD44 activation can act at the level of the LSC, H90 was administered to NOD/SCID mice transplanted with primary AML cells. We show that H90 greatly impairs leukemic repopulation by up to 95% compared to mice injected with control antibody. In addition, posttreatment grafts exhibited a much reduced level of primitive cells and an increase in immunophenotypically differentiated cells. The absence of leukemia in serially transplanted mice established direct targeting of LSC. The mechanism of H90 induced LSC loss involves both a promotion of LSC commitment and an impairment of their homing to supportive microenvironments.

16 DIAGNOSING PNH AND PREVIOUSLY UNDIAGNOSED ACUTE LEUKEMIAS WITH FLAER AND MULTIPARAMETER FLOW CYTOMETRY

D. Robert Sutherland1, Nancy Kuek1, Jeff Davidson1, Sylvia Lynn Bamford2, Michael Keeney3 1University Health Network, Clinical Flow Cytometry, Toronto, Ontario, Canada; 2London Health Sciences Centre, Flow Cytometry, London, Ontario, Canada; 3London Health Sciences, Hematology/ Flow Cytometry, London, Ontario, Canada

Paroxysmal Nocturnal Hemoglobinurea (PNH) is an acquired Hematopoietic Stem Cell disorder caused by a somatic mutation in the X-linked pig-a gene. This results in a partial or absolute deficiency of all glycophosphatidyl-inositol (GPI)-linked proteins/glycoproteins. The classical approach to diagnosis of PNH by cytometry involves the loss of at least 2 GPI-linked antigens (typically CD55 and CD59) on two different cell lineages (RBCs and Neutrophils). The bacterial lysin Aerolysin binds to the GPI moiety of cell surface GPI-linked molecules and causes lysis of normal cells but not GPI-deficient PNH cells. FLAER is a fluorescently-labeled inactive variant of aerolysin that does not cause lysis of cells to which it binds and this reagent is becoming more widely used in the diagnosis of PNH by Flow. In a single tube assay, we have combined FLAER with CD45, CD33 and CD14 that allows the simultaneous analysis of FLAER and the GPI-linked CD14 structure on neutrophil and monocyte lineages. Comparison to standard CD55 and CD59 analysis shows excellent agreement. The assay can be performed up to 48 hours after sample draw and data interpretation is straightforward. Additionally, we were able to detect fewer than 5% PNH-like monocytes and neutrophils in several cases of aplastic anemia, which we were otherwise unable to detect using CD55 and CD59 on red blood cells. Due to the higher signal to noise ratio, the method shows increased sensitivity in our hands over single (CD55 or CD59) parameter analysis. Interestingly, we have also detected leukemic blasts which show aberrant FLAER staining in several samples sent to us for ‘PNH testing’ including 1 case each of AML-M1, erythroleukemia (M6), a case of acute leukemia developed in a patient with a history of CMML and two cases of acute myelomonocytic leukemia. In all of these cases, the neutrophils stained normally with FLAER, thereby ruling out PNH, while the gated CD33bright cells failed to express CD14 and bound lower levels of FLAER.

17 HIGH CONTENT ANALYSIS IN DRUG DISCOVERY

Joseph Trask1 1Abbott Laboratories, Target and Lead Discovery, Abbott Park, Illinois

This talk will describe past, current and future trends of the use of high-content analysis (HCA) and high-content screening (HCS) in the biopharmaceutical industry and the crossover of the technology into the academic arena. The term “HCA/HCS” typically describes automated fluorescent imaging, image analysis, data management and the applications thereof. The technology not only complements flow cytometry technology, it resembles flow cytometry during its infancy with many challenges and a rapidly changing future. The impact of HCA/HCS technology in the biopharmaceutical industry is being felt throughout the entire drug development process from early drug discovery, target identification, target validation, screening through preclinical biomarker discovery including toxicology and mechanism of action studies. The technology has cross-pollinated into many areas of science including basic science and even material sciences. The goal of the talk is to provide the audience with a brief history of HCA/HCS and case studies where the technology has made an impact.

18 RARE EVENT DETECTION IN SOLID CANCERS

Alison L. Allan1, Michael Keeney2 1University of Western Ontario, Oncology, Schulich School of Medicine & Dentistry, London, Ontario, Canada; 2London Health Sciences Centre, Hematology/Flow Cytometry, London, Ontario, Canada

Given the multi-step nature of cancer development, there should be several opportunities for therapeutic targeting of tumor cells and/or the tumor microenvironment. The ideal way to identify and monitor disease progression is through surrogate marker approaches that are minimally invasive and allow for longitudinal testing, such as blood tests. Our current research focuses on the development of such approaches, in particular rare event detection by image and flow cytometric methods. Identifying rare populations requires a different approach than standard cytometry techniques, which rely mainly on positive and negative decisions made in either one, or at most, two dimensional space. Recent interest in identification and quantification of rare cell populations such as circulating epithelial tumor cells and circulating endothelial cells in cancer patients has pushed the limits of detection even further. Flow and image cytometric methods are now being developed to identify cellular populations with frequencies as low as 1-20 cells/ml. This presentation will discuss the issues that must be addressed when designing an assay to accurately detect rare populations of cells in blood or bone marrow, with emphasis on detection of circulating endothelial cells and circulating tumor cells in patients with solid tumors and in experimental mouse models of cancer.

19 IMAGE-BASED SCREEN FOR CELL CYCLE AND CANCER TARGETS

Daniel R. Rines1 1Genomics Institute of the Novartis Research Foundation (GNF), GNF Bio-Imaging Center, San Diego, California

Chromosome segregation during mitosis depends on the proper function of specialized structural and cytoskeletal machinery. The duplicated chromosomes are separated equally to daughter cells by the highly dynamic fibers of the mitotic spindle called microtubules. The spindle consists of a bipolar array of microtubules where the extreme ends of the spindle are each anchored to a centrosome. Kinetochores are large protein complexes that assemble onto centromeric DNA sequences and physically attach the replicated chromosomes to the spindle fibers. Ultimately, the maintenance of genomic integrity depends on the proper attachment of chromosomes to the spindle and on the generation of opposing tensile forces that pull the chromosomes apart. Failure in either of these processes leads to unequal partitioning of the genome. However, little is known about how chromatid-microtubule attachment is mediated, or how opposing forces are generated. Currently, two anticancer agents, paclitaxel (taxol) and camptothecin, are used in the treatment of various forms of the disease. Taxol promotes irreversible polymerization of microtubules, disrupting their inherent dynamic nature. Camptothecin functions by inhibiting topoisomerase I activity and leads to large scale chromosome breakage when opposing tensile forces are applied. The diverse action of these two anti-mitotic compounds and the mechanical complexity of the segregation process suggest that many protein components are involved. In fact, recent studies in more genetically tractable organisms such as the budding yeast, S. cerevisiae, have identified over 50 proteins involved in the chromatid-microtubule attachment process alone and many of the functional orthologues have yet to be identified in humans. Using a RNA library of 49,000 double-stranded (ds)RNA targeting approximately 24,000 genes, we performed a loss-of-function screen for essential mitotic chromosome segregation genes. We identified novel genes whose inactivation caused mitotic arrest. Multi-parametric analysis of image-based data derived from a high-content screen including phospho-histone H3 levels, cellular proliferation and nuclear morphology allowed us to isolate both checkpoint and independent segregation genes.

20 A HUMAN PROTEIN ATLAS FOR NORMAL AND CANCER TISSUES

Mathias Uhlen1, Fredrik Ponten2 1Stockholm, Sweden; 2Uppsala University, Uppsala, , Sweden

Antibody-based proteomics provides a powerful approach for the functional study of the human proteome involving the systematic generation of protein-specific affinity reagents. We have used this strategy to construct a comprehensive, antibody-based protein atlas for expression and localization profiles in 48 normal human tissues and 20 different cancers (1). The Human Protein Atlas is publicly available (www.proteinatlas.org) and contains, in the first version, approximately 400,000 high-resolution images corresponding to more than 700 antibodies towards human proteins. Each image has been annotated by certified pathologists to provide a knowledge base for functional studies and to allow queries about protein profiles in normal and disease tissues (2). Our results suggest it should be possible to extend this analysis to the majority of all human proteins thus providing a valuable tool for medical and biological research, in particular for biomarker analysis in various patient cohorts. Reference: (1) Uhlen M, Ponten F. (2005) Antibody-based Proteomics for Human Tissue Profiling. Mol Cell Proteomics 4(4): 384-393, (2) Uhlen et al (2005) A human protein atlas for normal and cancer tissues, Mol Cell Proteomics, 4(12):1920-1932.

21 FLOW AND IMAGE CYTOMETRIC FRET FOR DETECTING PROTEIN ASSOCIATIONS

János Szöllõsi1, György Vereb1, Gábor Horváth1, Péter Nagy1 1University of Debrecen, Department of Biophysics and Cell Biology, Medical and Health Science Center, Debrecen, , Hungary

Supramolecular organization of biomolecules at the cell surface or inside the cell has an important role in determining the function and integrity of cells. Specific techniques are available now for detecting molecular proximity and interactions in cells, such as flow or image cytometric variations of fluorescence resonance energy transfer (FRET). Flow cytometric techniques offer the advantage of rapid analysis on a large number of cells (~105 cells in some minutes) with a high statistical accuracy and a possibility for analyzing heterogeneity at the population level. Flow cytometry, however, does not provide any information about the spatial localization of fluorescent probes, but instead measures the fluorescence intensity averaged over each cell. In contrast, microscopic techniques provide a high spatial resolution: conventional fluorescence microscopies have a ~250 nm resolution limited by diffraction of the optics. Although microscopies have several further advantages in detecting molecular dynamics of changes in the distribution or intensity of fluorescent probes, they suffer from a low statistical reliability, especially in the case of quantitative measurements. Thus, a combined application of flow and image cytometry in resolving particular biological questions can be a very powerful approach. In flow cytometry we applied fluorescent probes with longer wavelength excitation and multiple wavelength detection in the emission regions so that autofluorescence correction could be performed on a cell by cell basis in FRET analysis. These facts improved the accuracy of the FRET method and cells with low receptor expression, such as HPB-ALL cells transfected with various CD45 isoforms were amenable to FRET investigation. Combination of various forms of flow and image cytometric FRET methods revealed distinctive expression and association pattern of ErbB receptor tyrosine kinases on the surface of various cancer cell lines sensitive or resistant to trastuzumab (Herceptin®). Simultaneous application of image cytometric FRET methods based on donor and acceptor photobleaching provided a useful dual FRET approach revealing a unique coassociation pattern of integrins, CD44 and ErbB2 on the surface of tumor cells. By measuring the distances between various monoclonal antibody epitopes on ErbB2 molecules and the distances between epitopes and the cell membranes useful information was provided for positioning the extracellular domain in molecular modeling the nearly full length ErbB2 dimer. In this model favorable dimerization interactions were predicted for the extracellular, transmembrane and protein kinase domains, which may act in coordinated fashion in ErbB2 homodimerization, and also in heterodimers of ErbB2 with other members of ErbB family.

22 DO NOT MIND THE GAP: PROTEIN TRAFFICKING BETWEEN THE ENDOPLASMIC RETICULUM AND THE GOLGI APPARATUS IN PLANT CELLS

Federica Brandizzi1 1University of Saskatchewan and Michigan State University, Saskatoon/East Lansing, Saskatchewan/Michigan, Canada

Secretory materials are synthesized on the surface of the endoplasmic reticulum (ER)1. They are then shipped from the ER to the Golgi apparatus to be sorted either back to the ER or to distal secretory compartments such as vacuoles and plasma membrane. It is vital for a cell to regulate protein transport between these organelles. The ER and Golgi are closely associated in plant cells2,3 (Fig. 1). How these two organelles communicate with each other in plant cells is an important question that remains largely unanswered. To provide further understanding of the regulation of protein export from the plant ER, we have explored the mechanisms of protein trafficking between the ER and the Golgi apparatus using live cell imaging techniques. It appears that plant cells contain multiple mobile Golgi stacks distributed over the entire cytoplasm. These stacks move with the ER by means of actin-myosin motors3,4. The domains of the ER dedicated to the export of proteins, the ER export sites (ERESs), form secretory units that move along the surface of the ER together with the Golgi stacks4,5. We also found that the integrity of Golgi and ERESs is regulated by the activity of specific GTPases, such as Sar1 and Arf14,5. Finally, we determined the existence of a stringent signal-regulated mechanisms for ER export of multispanning, type I and type II membrane proteins6. For example, we found that mutations of a specific di-acidic motif (DXE) in the cytosolic tail of proteins such as CASP, a Golgi matrix protein with a type II membrane topology7, cause a reduction of the export of this protein from the ER6. ER export of type I and multispanning membrane proteins appears to be similarly regulated6. Our results indicate that in plant cells the ER and Golgi form a dynamic membrane system whose components continuously cycle through the ER via a regulated membrane trafficking pathway. References: 1. Nicchitta CV. Curr Opin Cell Biol 2002;14(4):412-6. 2. Boevink et al. Plant J 1998;15(3):441-7. 3. Brandizzi et al. Plant Cell 2002;14(6):1293-309. 4. daSilva et al. Plant Cell 2004;16(7):1753-71. 5. Stefano et al. Plant J 2006; in press. 6.

Hanton et al. Plant Cell 2005;17(11):3081-93. 7. Renna et al. Plant Mol Biol 2005;58(1):109-22.

Confocal image of a tobacco leaf epidermal cell transformed with ERD2-YFP, a Golgi and ER marker3. Note that Golgi bodies (arrow) are in close association with the ER network. Scale bar = 5 microns

Parallel Sessions

23 COHERENT ANTI-STOKES RAMAN SCATTERING (CARS) MICROSCOPY FOR LABEL-FREE, CHEMICALLY-SELECTIVE BIOMEDICAL IMAGING

Conor L. Evans1, Jeanette Kurian1, Eric O. Potma2, Mehron Pourgish’Haag3, Daniel Cote3, Charles P. Lin3, X. Sunney Xie1 1Harvard University, Chemistry and Chemical Biology, Cambridge, Massachusetts; 2University of California, Irvine, Chemistry, Irvine, California; 3Massachusetts General Hospital, Wellman Center for Photomedicine, Boston, Massachusetts

Advances in biomedical imaging have revolutionized our ability to visualize living organisms at the cellular and sub-cellular levels. Despite these developments, in vivo imaging with chemical contrast remains a challenge as molecular selectivity typically requires the introduction of specific labels. Many applications in biology and medicine would significantly benefit from a noninvasive imaging technique that circumvents such exogenous probes. In vivo microscopy based on vibrational spectroscopic contrast offers a unique approach for visualizing tissue architecture with chemical specificity. Coherent-anti-Stokes Raman scattering (CARS) microscopy is a non-linear imaging technique capable of rapid vibrational imaging of thick biological specimens. Backscattering of the intense forward propagating CARS light in tissue gives rise to a surprisingly strong epi-CARS signal that makes in vivo imaging possible. This substantial signal allows for real-time monitoring of dynamic processes, such as the diffusion of chemical compounds, in tissues [Evans et al. PNAS 102, 16807 (2005)]. By specifically tuning into the CH2 stretching vibrational frequency, we demonstrate CARS imaging and spectroscopy of lipid rich tissue structures in mouse skin, including sebaceous glands, corneocytes and adipocytes, with unprecedented contrast at subcellular resolution.

24 QUANTITATIVE LIVE IMAGING DESCRIBES MORPHOGENETIC NUCLEAR MOVEMENTS IN EARLY DROSOPHILA EMBRYO

Cris Luengo1, Soile Keränen2, Charless Fowlkes3, Gunther Weber4, Min-Yu Huang4, Oliver Rübel4, Bernd Hamann4, Damir Sudar1, Jitendra Malik3, Mark D. Biggin2, David W. Knowles1 1Lawrence Berkeley National Laboratory, Life Sciences Division, Berkeley, California; 2Lawrence Berkeley National Laboratory, Genomics Division, Berkeley, California; 3University of California, Berkeley, Computer Science Division, Berkeley, California; 4University of California, Davis, Department of Computer Science, Davis, California

The Berkeley Drosophila Transcription Network Project (bdtnp.lbl.gov) is conducting a system-wide analysis of the transcription network in the early Drosophila embryo. As part of this multidisciplinary effort, novel imaging, image analysis and visualization methods have been developed to construct the first three-dimensional (3D) atlas of gene expression and morphology in an embryo at cellular resolution. Our aim is to quantify the relative expression of hundreds of genes in wild type embryos and in a series of mutant embryos, and to map these results onto “stereotypical embryos”. Multiple-color in-situ hybridizations are used to fluorescently label gene products of interest, and total DNA is counter-stained. High resolution, multi-channel, 3D images are acquired of entire embryos using two-photon excitation. Individual nuclei are isolated from the DNA-stained images using novel, automated segmentation techniques, and the relative gene expression within and around each nucleus is then quantified. Novel techniques have been developed to register data from many images onto a “stereotypical embryo” and create exquisite quantitative visualizations of the data in 3D. One novel observation we have made is the systematic change in nuclear packing densities during stage 5 (interphase cycle 14, up to gastrulation), which can be seen by comparing fixed embryos of different ages. To understand these nuclear movements, we have studied the process in live histone2A-GFP embryos. Individual embryos were imaged from the 13th cleavage cycle to the start of gastrulation in approximately 3 minute intervals. Rapid temporal sequences were important for tracking individual nuclei but restricted the imaging to the portion of the embryo closest to the objective lens. Orientation of the imaged embryo portions were determined by morphological features during gastrulation and egg-length was determined from optical sections taken through the middle of the embryo. These measurements allowed images from multiple embryos to be combined into whole-embryomaps. The resulting patterns of nuclear packing density and flow-fields correlate with the dorsal-ventral orientation of the embryo and the future location of the ventral furrow. These results, which support our fixed embryo work, show complex 3D nuclear movements prior to gastrulation that will have to be considered to fully understand dynamics in gene expression patterns.

25 ACQUIRING MULITPLE IMAGES OF LARGE TISSUE SECTIONS IN BOTH FLUORESCENCE AND TRANSMITTED LIGHT USING THE LASER SCANNING CONFOCAL TISSUESCOPE

Trudey Nicklee1, David Hedley2 1Toronto, Ontario, Canada; 2Princess Margaret Hospital, Toronto, Ontario, Canada

Large tissue sections that overfill a microscope 10x objective field of view typically must be imaged using a tiling method. In tiling, sequential fields of view are acquired as separate image files. This is time consuming, especially when algorithms are employed to align edges of individual fields. Furthermore, depending on the quality of the stage movement and algorithms used, artifacts may be introduced from misaligned fields. The Biomedical Photometrics TISSUEscope (Waterloo, Ontario; confocal.com) is a laser confocal scanning microscope, able to acquire a low resolution image of an entire microscope slide as a single continuous 20 mm x 70 mm field in 30 seconds. Large subsections of interest can then be imaged at selected resolution to 1µm per pixel. The instrument is equipped with blue, green and red lasers, and can simultaneous acquire images from two lasers. Software allows for the same selected field of view to be repeatedly scanned with different excitation and emission parameters. Therefore, multiple fluorescent images of this same field of view are acquired aligned. This allows not only for quantification of several markers in a single section, but also co-localization studies of these markers. As well as allowing rapid image acquisition compared to tiled field imaging at comparable resolution using a conventional fluorescence microscope, the system also incorporates transmission detectors that allow RGB imaging based on absorbance from the three lasers. A fluorescently stained slide can therefore be imaged, then restained and imaged for transmitted light using the same optical system. This allows selected areas of interest to be identified by transmitted light, then directly linked to the fluorescence images. Wide field multispectral analysis of histological sections is a powerful technique for studying complex molecular processes at the intact tissue level. The laser scanning TISSUEscope is a novel instrument that offers several advantages that we are currently evaluating. Applications include the analysis of signaling pathways in sequential biopsies obtained from patients in clinical trials of molecular cancer therapeutics, and studies that address the problems of intratumoral heterogeneity.

26 COMPARISON OF FLUORESCENTLY AND CHROMATIC LABELED TISSUE MICROARRAYS ANALYZED BY LASER SCANNING CYTOMETRY

Ed Luther1 1CompuCyte Corporation, Cambridge, Massachusetts

Tissue microarrays (TMAs) are becoming invaluable tools in biomarker development. In developing automated analysis systems, the choice between fluorescent or chromatic staining techniques is a primary consideration. We have performed an evaluation comparing the two staining techniques. Materials and Methods: TMAs consisting of 121 elements (0.5 mm cores) were stained with either fluorescent or chromatic dyes and then submitted for blind analysis on a laser scanning cytometry platform. Control samples and breast cancer tissues were included. Serial sections of the arrays were stained with antibodies against HER2/neu protein and counterstained for DNA, either with chromatic reagents (DAB counterstained with hematoxylin) or fluorescent reagents (Alexa Fluor 488 counterstained with propidium iodide). The slides were analyzed on an iCyte® Automated Imaging Cytometer. High-speed scans were used to locate individual core elements within the array. High-resolution (0.25 micron) scans were then performed on each element to obtain either fluorescence or laser light absorption signals. Spectral deconvolution was used to separate the HER2 and DNA staining. In the chromatically stained sections, compensation techniques were applied for tissue autofluorescence. Scanned images were segmented using both nuclear segmentation and random sampling analysis. Results: In both TMA sets, the nuclear segmentation and random segmentation techniques (chromatic R2 = 0.9017, fluorescence R2 = 0.8048) correlated well. The correlation between the values from the chromatic and fluorescent labeled slides was less satisfactory—R2 = 0.6595. To investigate the discordance, analysis regions were defined around core elements falling into the following categories, laser scan images of representative elements were analyzed, and the staining patterns of the cores were confirmed. Category Chromatic Fluorescent Diagnosis 1 + + HER2/neu positive 2 + -HER2/neu positive – below fluorescence threshold 3

+ Autofluorescence artifacts 4 --Negative Conclusions: Our analysis showed greater sensitivity for TMAs stained with chromatic dyes than for those with fluorescent dyes. This is contradictory to the current belief that fluorescent dyes have greater quantitative capabilities than chromatic IHC dyes, and is probably due to complications from autofluorescence of the tissues. The ability to analyze both chromatic and fluorescent TMAs on the same instrument platform allows investigators great flexibility in selecting an appropriate staining technology - fluorescence, chromatic or both.

27 HYPERCHROMATIC CYTOMETRY PRINCIPLES FOR CYTOMICS BY SLIDE BASED CYTOMETRY

Attila Tárnok1, Mittag Anja1, Wiebke Laffers2, Dominik Lenz3, Andreas Gerstner2 1Cardiac Center, University of Leipzig, Research Laboratory, Pediatric Cardiology, Leipzig, Saxony, Germany; 2University Bonn, Bonn, Nordrhein-Westfalen, Germany; 3Purdue University, Purdue University Cytometry Laboratories, West Lafayette, Indiana

Multicolor and polychromatic analysis of biological specimens has become increasingly important due to the emerging new fields of high-content and high-throughput single cell analysis for Systems Biology and Cytomics. Combining different technologies and staining methods polychromatic analysis can be pushed further forward to virtually measure anything stainable in a cell. We termed this approach hyperchromatic and present different components suitable to be combined for achieving this task. For cell analysis Slide Based Cytometry (SBC) technologies are ideal as, unlike flow cytometry, it is a non-consumptive method, i.e. the analyzed sample is fixed on the slide and can following manipulation of the object be subsequently reanalyzed. In this overview we demonstrate on a SBC instrument, the Laser Scanning Cytometer, various approaches for hyperchromatic analysis. The different components demonstrated here are: 1) polychromatic cytometry (staining of the specimen with eight or more different fluorochromes simultaneously), 2) iterative restaining (using the same fluorochrome for restaining and subsequent reanalysis), 3) differential photobleaching (differentiating fluorochromes by their different photostability), 4) photoactivation (activating fluorescent nanoparticles or photocaged dyes), and 5) photodestruction (destruction of FRET dyes). Based on the feature of relocating cells that are immobilized on a microscope slide the identical cells can be subsequently reanalyzed and the data collected on the single cell level after manipulation steps. With the intelligent combination of several different techniques hyperchromatic cytometry allows to quantify and analyze virtually all components of relevance on the identical cell. The information gained per specimen is only limited by the number of available antibodies and by sterical hindrance.

28 A MULTIMODE ENDOSCOPE FOR SIMULTANEOUS MACROSCOPIC AND MICROSCOPIC IMAGING OF TISSUES IN VIVO

Silas J. Leavesley1, Bartlomiej Rajwa2, J. Paul Robinson3 1Purdue University, Biomedical Engineering, Weldon School of Biomedical Engineering, West Lafayette, Indiana; 2Purdue University, Basic Medical Sciences,Veterinary Medicine, West Lafayette, Indiana; 3Purdue University, Basic Medical Sciences & Biomedical Engineering,West Lafayette, Indiana Diagnosis of pathologies often includes gathering information using various diagnostic medical imaging modalities, and as a result of this information, the possible biopsy of tissues for further analysis. In many cases, the region(s) in which to perform a biopsy are detected and delineated by diagnostic images. Pathologies of the alimentary, respiratory, and urinary systems often make use of endoscopic imaging modes (mainly traditional and fluorescence endoscopy) to detect potential lesions, and use biopsy as a method for confirming the nature of the detected lesion. Thus, increasing the sensitivity of endoscopic diagnosis will aid in correctly delineating the boundaries of detected lesions, and increasing the specificity of endoscopic techniques may help to decrease the total number of biopsies taken. This work outlines the development of a new type of endoscope that features a forward-facing macroscopic video imaging port, and a side-facing microscopic imaging port. Both of these modes of imaging can operate simultaneously, and both can be operated in reflected light and fluorescence modes, allowing a physician to “zoom-in” on potential lesions and inspect their cellular makeup. The ability to inspect these suspected areas should decrease the number of false positive diagnoses, which could serve to decrease the number of biopsies, in many cases. This is appealing for two reasons, first it will serve to reduce tissue damage and pain to patients; second, it will reduce some costs associated with unnecessary biopsies. In addition, with the advanced software used in this system, the physician has greater control over what is actually imaged. Thus, this endoscope advances the technology in this field by delivering quality, high-resolution microscopic images with simultaneous macroscopic location information.

Image Processing and Analysis 1

29 TOPOLOGY PRESERVING STACS SEGMENTATION OF PROTEIN SUBCELLULAR LOCATION IMAGES

Amina Chebira1, Gowri Srinivasa1, Lionel Coulot2, Heather Kirschner3, Jose M. F. Moura3, Jelena Kovacevic1, Elvira Garcia Osuna4, Robert F. Murphy5

1Carnegie Mellon University, Biomedical Engineering, Carnegie Institute of Technology, Pittsburgh, Pennsylvania; 2EPFL, Lausanne, Switzerland; 3Carnegie Mellon University, Electrical and Computer Engineering, Pittsburgh, Pennsylvania; 4Carnegie Mellon University, Biomedical Engineering, Pittsburgh, Pennsylvania; 5Carnegie Mellon University, Biological Sciences and Biomedical Engineering, Pittsburgh, Pennsylvania We present an algorithm for the segmentation of multicell fluorescence microscopy images. Such images abound and a segmentation algorithm robust to different experimental conditions as well as cell types is becoming a necessity. In cellular imaging, among the most often used segmentation algorithms is seeded watershed. One of its features is that it tends to oversegment, splitting the cells, as well as create segmented regions much larger than a true cell. This can be an advantage (the entire cell is within the region) as well as a disadvantage (a large amount of background noise is included). We present an algorithm which segments with tight contours by building upon an active contour algorithm—STACS proposed by Pluempitiwiriyawej at al. We adapt the algorithm to suit the needs of our data and use another technique, topology preservation proposed by Han et al, to build our topology preserving STACS (TPSTACS). Our algorithm significantly outperforms the seeded watershed both visually (see Figure, seeded watershed on the left, TPSTACS on the right) as well as by standard measures of segmentation quality (see Table).

SW [%] TPSTACS [%]
Area Similarity (AS) 30.8 80.5
Area Overlap (AO) HS 62.2 82.1
DNA 62.3 99.8
Recall (R) HS (T=70%) 37.9 71.1
DNA (T=95%) 36.8 99.1
Precision (P) HS (T=70%) 40.0 76.8
DNA (T=95%) 36.3 99.1

30 TWO AND THREE DIMENSIONAL SEGMENTATION OF WHOLE CELLS AND CELL NUCLEI IN TISSUE

Dean P McCullough1, Daniel Baggett2, Stephen J. Lockett3 1National Cancer Institute,Advanced Biomedical Computing Center, Frederick, Maryland; 2Worcester Polytechnic Institute, Mechanical Engineering, Worcester, Massachusetts; 3NCI / SAIC-Frederick, Frederick, Maryland

Communications between neighboring cells in large part drive tissue development and function, as well as disease-related processes such as tumorigenesis. In order to understand the molecular basis of these processes, it is necessary to quantitatively analyze specific molecules in adjacent individual cells or cell nuclei of the intact tissue. A major bottleneck preventing widespread use of such analyses is the lack of an efficient method that assures correct segmentation of all individual, whole cells in a given intact tissue volume of interest from 3D images. Consequently, we have developed software for identifying the optimum border around each individual cell or cell nucleus, a process known as segmentation, from 2D and 3D microscope images of intact tissue labeled with a fluorescent cell or nuclear surface marker. In the 2D case the optimum border was defined as the border that has an average intensity per unit length greater that any other possible border around the same cell or nucleus. Implementation of the algorithm required the user to indicate two points for each cell, one inside the cell and the other on the border. Thereafter segmentation was automatic and was peformed using dynamic programming. The method correctly detected virtually 100% of cells, because determination of the optimum path is not significantly affected by intermittent labeling of the cell borders, by diffuse borders, or by spurious signals away from the borders. It also contains interactive tools, which allows subsequent visualization and correction of the image. The method is also highly efficient due to only minimal user interaction. We have extended this method to 3D segmentation, which begins with 2D segmentation in a user-selected plane approximately through the center of the cell. Then the automatic algorithm separately finds the two surfaces of the cell in the planes above and below the user selected plane using dynamic programming. The algorithm does not find the true optimal surface since this is too computationally expensive, but closely approximates the optimum by finding a succession of partially optimal surfaces using the greedy algorithm with a look ahead of n steps. Following segmentation, the user may add points that are required to be on the surface to correct any perceived errors. The algorithm has been tested on a wide variety of biological tissue samples and will segment moderately irregularly shaped cells containing concavities. Work performed under contract grant sponsor: NCI/NIH; Contract #: NO1-CO56000.

31 A GENERAL TECHNIQUE FOR SEGMENTATION OF INDIVIDUAL CELLS IN LIGHT MICROGRAPHS

Zachary Pincus1, Julie A Theriot2 1Stanford University, Biomedical Informatics, School of Medicine, Stanford, California; 2Stanford University, Biochemistry, School of Medicine, Stanford, California

Many ad hoc methods exist for separating cells from the image background (and, with less success, from each other) in light micrographs. Here we present a general method that is applicable to many cell types and imaging modalities. A persistent difficulty with cell segmentation tools is that assumptions about cell shape, imaging conditions, and cell packing are “hard-coded” into the cell-finding logic. We instead make these assumptions explicit and modular. By using a parameterized “shape model” learned from training examples, our tool makes no implicit assumptions about cell shape. Performing the principal components analysis on cell outlines provided by the user produces a set of linearly independent modes of shape variation (e.g. large vs. small, round vs. elongated, etc.). These shape modes can then be recombined to generate candidate cells from a distribution of expected shapes. Because the only input required is a small set of shapes, it is easy to reconfigure this module for different cell types. We free our method from assumptions about the relationship between pixel values and the presence or absence of cells by converting images into a canonical form. Specifically, we use machine learning tools to convert images into “probability maps” where the value of each pixel is the likelihood that that pixel is inside of a cell. Simple k-nearest-neighbor classification of pixels based on local texture statistics is sufficient to transform images of many different types (e.g. phase contrast, DIC, epifluorescence) into simple-to-interpret probability maps. The only required inputs are a few image regions which have been manually labeled as “cells” or “background;” thus this module is also easy to reconfigure for different imaging conditions. To find a single cell in an image, a shape model is iteratively fit to a probability map. We numerically optimize the parameters of a given shape model (creating different candidate shapes) and its pose (x- and y-position and rotation) to maximize a goodness-of-fit function which evaluates how well the model fits to the probability map. This function evaluates the prior likelihood of the candidate shape, the distance between candidate shape edges and image edges, and the fraction of pixels with low likelihood of being in a cell that are nevertheless inside the candidate shape. We then refine the initial fit by deforming the shape to better fit the image within a level-set framework. This process is repeated to find all cells in an image. This method has shown human-competitive results in separating out individual cells from the background and from each other on many different image and cell types, including fixed S2 cell cultures, growing bacterial mats, and membrane-stained Drosophila epithelia.

32 FILO: AN UNBIASED SPATIAL ANALYSIS OF FISH SIGNALS IN INTERPHASE NUCLEI

Prabhakar Reddy Gudla1, Addison Z Yee2